SPA
VCYT icon

Sherbrooke Park Advisers’s Veracyte VCYT Stock Holding History

Sherbrooke Park Advisers’s Portfolio VCYT Stock Details VCYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-9,330
Closed -$252K – 730
2025
Q2 		$252K Buy
+9,330
New +$270K 0.11% 341
2025
Q1 		– Sell
-9,493
Closed -$376K – 957
2024
Q4 		$376K Buy
9,493
+618
+7% +$23.4K 0.12% 309
2024
Q3 		$302K Buy
+8,875
New +$250K 0.07% 564
2024
Q2 		– Sell
-26,602
Closed -$590K – 1220
2024
Q1 		$590K Buy
+26,602
New +$649K 0.11% 307

Other funds holding VCYT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Sherbrooke Park Advisers's VCYT Position: Q3 2025 in Review

Sherbrooke Park Advisers sold out of Veracyte (VCYT) in Q3 2025, closing a stake of 9,330 shares — an estimated $252K sold.

Sherbrooke Park Advisers first reported a position in VCYT in Q1 2024 and held it in 4 quarters. The position peaked at $590K in Q1 2024. 298 funds tracked by Wall St. Rank hold VCYT as of Q3 2025.

  • Sherbrooke Park Advisers reported no remaining Veracyte position as of Q3 2025 after selling out during the quarter.
  • Sherbrooke Park Advisers sold 9,330 Veracyte shares in Q3 2025, an estimated $252K.
  • Sherbrooke Park Advisers first reported a position in Veracyte in Q1 2024 and held it in 4 quarters.
  • Sherbrooke Park Advisers's Veracyte position peaked at $590K in Q1 2024.
  • 298 funds tracked by Wall St. Rank held Veracyte as of Q3 2025.

Based on Sherbrooke Park Advisers's 13F filing for Q3 2025, filed 14 Nov 2025.